Evidium

Evidium builds world models for healthcare — computational representations of clinical states and disease progression. The platform projects patient trajectories over a map of conditions and the transitions between them, enabling payers and providers to forecast severity, cost trajectories, and intervention outcomes.

The firm explicitly distinguishes its Computational Medical Intelligence from generative AI. While LLMs discuss medical knowledge, Evidium computes the dynamics of disease progression. Its model is built on causal maps of clinical states and transitions, grounding every insight in traceable clinical evidence and real-world events rather than probabilistic text generation.

Evidium's disclosed investors include Health2047, the venture studio of the American Medical Association; WGG Partners, a specialist deep-tech fund with early-stage backing of x.AI and Perplexity; PGV; Interwoven Ventures; and Mindset Ventures, alongside other specialist funds and individuals, per the firm's website.

The platform is designed for four segments: self-insured employers seeking cost-trajectory forecasting, health plans managing population risk and pricing, hospitals and health systems coordinating longitudinal treatment, and research organizations modeling therapeutic impact and real-world evidence.

The firm states its models support, rather than replace, expert judgment. Insights are designed to inform clinical and financial decisions by making disease dynamics computationally visible, with each projection traced to underlying clinical evidence.